Abstract
The basic claims of this application involve methods that use a polymer to deliver therapeutic molecules in a targeted fashion using a polymeric carrier, drug and a biologically degradable linker. The release of therapeutic molecule is in response to digestive enzymes that are overexpressed in diseased tissues in the body. Further claims, of the sixteen included, define the digestive enzymes and drug–polymer linkages that may be used and specify tumors as the disease of particular interest. Preclinical examples presented support the idea that this therapeutic design has merit. There does not seem to have a single clinical candidate but future work is expected to develop these molecules into clinical products for cancer and particularly cancer treatment combined with radiation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
